Citation Impact
Citing Papers
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring
2021 StandoutNobel
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
2003 StandoutNobel
Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsiveness
2015
Conventional cancer therapy: promise broken or promise delayed?
1998
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
2006 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
2006 Standout
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
Free radicals, metals and antioxidants in oxidative stress-induced cancer
2006 Standout
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers
2000
Proliferation and hypoxia in human squamous cell carcinoma of the cervix: First report of combined immunohistochemical assays
1997
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
2010 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Going APE over ref-1
2000
Predicting outcomes in radiation oncology—multifactorial decision support systems
2012
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
2014 Standout
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
2003 Standout
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Exploiting tumour hypoxia in cancer treatment
2004 Standout
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Radiosensitive melanoma cell line with mutation of the gene for ataxia telangiectasia
1998
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
1997
The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300
1999
Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression
2001 StandoutNobel
RU486 Increases Radiosensitivity and Restores Apoptosis through Modulation of HPV E6/E7 in Dexamethasone-Treated Cervical Carcinoma Cells
2000
Photodynamic therapy and anti-tumour immunity
2006 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002
2003
Individualization of cancer treatment from radiotherapy perspective
2012
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Photodynamic therapy of cancer: An update
2011 Standout
Exploring the role of cancer stem cells in radioresistance
2008
Relationship between DNA damage, rejoining and cell killing by radiation in mammalian cells
1996
Dysregulated pH: a perfect storm for cancer progression
2011 Standout
HIF-1α, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors
2002 StandoutNobel
The molecular landscape of head and neck cancer
2018 Standout
Vaccine and antibody-directed T cell tumour immunotherapy
2004
HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story
1999
Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells
2005 StandoutNobel
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
2001 Standout
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
MHC antigens and tumor escape from immune surveillance
2001
Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression
2001 StandoutNobel
Differential sensitivity of human papillomavirus type 16+ and type 18+ cervical carcinoma cells to CD95-mediated apoptosis
2001 StandoutNobel
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Strategies to improve radiotherapy with targeted drugs
2011
A review of human cell radiosensitivity in vitro
1996
Ionizing radiation activates IGF-1R triggering a cytoprotective signaling by interfering with Ku-DNA binding and by modulating Ku86 expression via a p38 kinase-dependent mechanism
2006
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
2005 StandoutNobel
Escape from immunotherapy: possible mechanisms that influence tumor regression/progression
2004
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage
2008
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Monitoring Radiotherapeutic Response in Prostate Cancer Patients Using High Throughput FTIR Spectroscopy of Liquid Biopsies
2019
Tumor vascularity: a histological measure of angiogenesis and hypoxia.
2001
Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix.
2001 StandoutNobel
The Three Es of Cancer Immunoediting
2004 Standout
Pharmacophore Guided Discovery of Small-Molecule Human Apurinic/Apyrimidinic Endonuclease 1 Inhibitors
2008
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
2001 Standout
Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells.
1997
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia
2000
Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.
2002
Transporter Associated with Antigen Processing**This article was accepted for publication on 1 October 1996.
1997
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.
2001
DNA Double-Strand Breaks
2002 StandoutNobel
Hepatitis C Virus Envelope Glycoprotein E1 Originates in the Endoplasmic Reticulum and Requires Cytoplasmic Processing for Presentation by Class I MHC Molecules
1999 StandoutNobel
Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer
2018 StandoutNobel
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy.
2001
Multiple Genetic Alterations Cause Frequent and Heterogeneous Human Histocompatibility Leukocyte Antigen Class I Loss in Cervical Cancer
2000
REDOX REGULATION BY INTRINSIC SPECIES AND EXTRINSIC NUTRIENTS IN NORMAL AND CANCER CELLS
2005
Works of RD Hunter being referenced
The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix
1997
Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix
1993
Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression
1995
Levels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers
1998